1. Requirement for manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers (a) In general Section 1128G(a) of the Social Security Act (42 U.S.C. 1320a–7h(a)) is amended by adding at the end the following new paragraph: (3) Certain product samples (A) In general In addition to the requirements under paragraphs (1)(A) and (2), on the 90th day of each calendar year (beginning with 2023), any applicable manufacturer that provides a payment or other transfer of value that is a product sample described in subparagraph (B) to any covered recipient (or to an entity or individual at the request of, or designated on behalf of, such a covered recipient) shall submit to the Secretary, in such electronic form as the Secretary shall require, the following information with respect to the preceding calendar year: (i) The total quantity of all such payments or other transfers of value provided to covered recipients. (ii) The total value of all such payments or other transfers of value provided to covered recipients. (iii) If applicable, information described in clauses (vii) and (viii) of paragraph (1)(A) with respect to such a payment or other transfer of value. (B) Product sample described For purposes of subparagraph (A), a product sample described in this subparagraph is a product sample that is not intended to be sold and is intended for patient use. . (b) Public availability of information Section 1128G(c)(1)(C) of the Social Security Act (42 U.S.C. 1320a–7h(c)(1)(C)) is amended— (1) in clause (ii)— (A) by striking (ii) contains and inserting (ii) (I) with respect to information that is not information submitted under paragraph (3) of subsection (a), contains ; (B) by striking , as applicable; and inserting , as applicable; and